North America holds a significant share of the inactivated vaccines market due to well-established healthcare infrastructure, high vaccination coverage, and increasing focus on disease prevention. The region benefits from ongoing advancements in vaccine technologies, favorable regulatory support, and expanding investments in public health initiatives, contributing to steady market growth...